Literature DB >> 6170296

Pharmacological and toxicological properties of azelastine, a novel antiallergic agent.

H J Zechel, N Brock, D Lenke, U Achterrath-Tuckermann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170296

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  18 in total

1.  Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance.

Authors:  U Achterrath-Tuckermann; T Simmet; W Luck; I Szelenyi; B A Peskar
Journal:  Agents Actions       Date:  1988-07

2.  A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.

Authors:  C A Gould; S Ollier; R Aurich; R J Davies
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

3.  Azelastine inhibits bronchial hyperreactivity to acetylcholine in guinea pigs.

Authors:  U Achterrath-Tuckermann; I Szelenyi
Journal:  Experientia       Date:  1988-12-01

Review 4.  Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

5.  Modulation of in vitro anaphylaxis of guinea-pig isolated tracheal segments by azelastine, inhibitors of arachidonic acid metabolism and selected antiallergic drugs.

Authors:  N Chand; W Diamantis; R D Sofia
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

6.  Influence of azelastine and some selected drugs on mucociliary clearance.

Authors:  U Achterrath-Tuckermann; V Saano; E Minker; F Stroman; I Arny; S Joki; J Nuutinen; I Szelenyi
Journal:  Lung       Date:  1992       Impact factor: 2.584

7.  Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis.

Authors:  Patricia B Williams; Elizabeth Crandall; John D Sheppard
Journal:  Clin Ophthalmol       Date:  2010-09-07

8.  Azelastine and allergen transduction signal in MC9 mast cells.

Authors:  K Fanous; R P Garay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

9.  A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design.

Authors:  Daniel Du; Darren Targett; Erhard Stolberg; Alessandra Canali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-17       Impact factor: 2.441

10.  Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.

Authors:  Friedrich Horak
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.